These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23805642)

  • 1. [Proteomics as a fundamental tool for subclinical screening, tests verification and assessment of applied therapy].
    Suchkov SV; Gnatenko DA; Kostiushev DS; Krynskiĭ SA; Pal'tsev MA
    Vestn Ross Akad Med Nauk; 2013; (1):65-71. PubMed ID: 23805642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular proteomic analysis.
    Suzuki T; Nagai R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):28-34. PubMed ID: 17350900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome].
    Cho WC
    Zhongguo Fei Ai Za Zhi; 2011 Aug; 14(8):C6-9. PubMed ID: 23676997
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteomics in cardiovascular surgery.
    Matt P; Carrel T; White M; Lefkovits I; Van Eyk J
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):210-4. PubMed ID: 17198814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.
    Ménoret A; Crocker SJ; Rodriguez A; Rathinam VA; Clark RB; Vella AT
    Proteomics Clin Appl; 2016 Jan; 10(1):8-24. PubMed ID: 26201056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases.
    Gianazza E; Tremoli E; Banfi C
    Expert Rev Proteomics; 2014 Dec; 11(6):771-88. PubMed ID: 25400095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular proteomics: challenges and opportunities for cardiologists of the future].
    Banfi C; Brioschi M; Tremoli E
    G Ital Cardiol (Rome); 2013; 14(7-8):495-503. PubMed ID: 23877547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.
    Percy AJ; Byrns S; Chambers AG; Borchers CH
    Expert Rev Proteomics; 2013 Dec; 10(6):567-78. PubMed ID: 24206229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biomarkers in the modern medical and biologic practice].
    Miroshnichenko II; Ptitsyna SN
    Biomed Khim; 2009; 55(4):425-40. PubMed ID: 20000121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing cardiovascular biology and medicine via proteomics: Opportunities and present challenges of cardiovascular proteomics.
    Ping P; Chan DW; Srinivas P
    Circulation; 2010 Jun; 121(21):2326-8. PubMed ID: 20516387
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical proteomics and new biomarkers in biological fluids].
    González-Buitrago JM; Ferreira L; Muñiz MC
    Med Clin (Barc); 2008 Oct; 131(11):426-34. PubMed ID: 18928725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Special Issue on Verification, Validation, and Uncertainty Quantification of Cardiovascular Models: Towards Effective VVUQ for Translating Cardiovascular Modelling to Clinical Utility.
    Steinman DA; Migliavacca F
    Cardiovasc Eng Technol; 2018 Dec; 9(4):539-543. PubMed ID: 30421097
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in cancer proteomics study].
    Chen ZC
    Ai Zheng; 2004 Feb; 23(2):113-7. PubMed ID: 14960226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of proteomics in prognosis and treatment of cardiovascular diseases].
    Zuk N; Dubis J; Witkiewicz W
    Przegl Lek; 2013; 70(3):143-8. PubMed ID: 24003669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: the use of proteomics as a research methodology for studying cancer-related fatigue: a review.
    Minton O; Stone PC
    Palliat Med; 2010 Apr; 24(3):310-6. PubMed ID: 20123948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics: clinical applications.
    Dominguez DC; Lopes R; Torres ML
    Clin Lab Sci; 2007; 20(4):245-8. PubMed ID: 18069451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way.
    Fert-Bober J; Murray CI; Parker SJ; Van Eyk JE
    Circ Res; 2018 Apr; 122(9):1221-1237. PubMed ID: 29700069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
    Zhao YY; Cheng XL; Lin RC
    Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of serum proteomics for detection of cancer: promise or only hope?
    Krueger KE
    Onkologie; 2006 Nov; 29(11):498-9. PubMed ID: 17068383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.